Cimetidine pharmacokinetics and dosage requirements in children

Related Experiment Video

Updated: Oct 8, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

A Somogyi, M Becker, R Gugler

    European Journal of Pediatrics
    |May 1, 1985
    PubMed

    Insights

    Children eliminate cimetidine faster than adults due to increased renal clearance. This study suggests a cimetidine dosage of 30 mg/kg daily for pediatric patients.

    Area of Science:

    • Pharmacology
    • Pediatric Medicine
    • Clinical Pharmacy

    Background:

    • Cimetidine is a widely used medication.
    • Understanding drug pharmacokinetics in children is crucial for safe and effective dosing.
    • Previous studies have indicated potential differences in cimetidine metabolism between pediatric and adult populations.

    Purpose of the Study:

    • To investigate the pharmacokinetics of cimetidine in children.
    • To compare cimetidine clearance, volume of distribution, and half-life in children versus adults.
    • To determine an appropriate cimetidine dosage regimen for pediatric patients.

    Main Methods:

    • Oral and intravenous administration of cimetidine (10 mg/kg) to pediatric subjects.
    • Pharmacokinetic parameter analysis including total body clearance, volume of distribution, and elimination half-life.
    • Comparison of pediatric data with existing adult pharmacokinetic data.

    Main Results:

    • Children exhibited significantly higher total body clearance (11.6 ml/min/kg) and a larger apparent volume of distribution (1.24 L/kg) compared to adults.
    • The elimination half-life of cimetidine was shorter in children (83 min) than in adults (122 min).
    • Renal clearance constituted 70% of total body clearance in children, more than double that of adults, with a negative correlation between age and renal clearance.

    Conclusions:

    • Children demonstrate significantly increased cimetidine elimination compared to adults, primarily driven by enhanced renal tubular secretion.
    • A recommended cimetidine dosage regimen for children is approximately 30 mg/kg per day, divided into three to four doses.
    • Further research into the specific mechanisms of enhanced renal transport in pediatric populations is warranted.

    More Related Videos

    Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

    Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

    Published on: October 5, 2017

    Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug08:28

    Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug

    Published on: December 14, 2021

    Related Concept Videos

    Dosage Regimens: Partial Pharmacokinetic Parameters01:01

    Dosage Regimens: Partial Pharmacokinetic Parameters

    It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...